Infographic: Comparing the effectiveness of bevacizumab to ranibizumab in patients with exudative age-related macular degeneration: the BRAMD study. (2023)
Attributed to:
Development of AAV gene therapy for blindness caused by cone-rod dystrophy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41433-023-02398-y
PubMed Identifier: 37085720
Publication URI: http://europepmc.org/abstract/MED/37085720
Type: Journal Article/Review
Parent Publication: Eye (London, England)
ISSN: 0950-222X